• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性切除治疗 Vater 壶腹癌的病理亚型的临床意义。

Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090. Epub 2011 Aug 31.

DOI:10.1002/jso.22090
PMID:21882202
Abstract

BACKGROUND

Ampullary cancer is considered to have a better prognosis than cancers of the distal bile duct and pancreas, and recent publications emphasize the prognostic importance of the histologic differentiation of the intestinal and pancreatobiliary types of ampullary cancer. The aims of this study were to identify those factors that affect recurrence after curative resection and to investigate differences between the clinicopathologic features of these two pathologic subtypes.

PATIENTS AND METHODS

The medical records of patients that underwent pancreatoduodenectomy for ampullary carcinoma from February 1995 to March 2009 at our institute were retrospectively reviewed. One hundred and four patients that underwent curative resection for ampullary carcinoma were enrolled in this study. One pathologist reviewed all pathologic reports and histopathologic findings. Data on clinicopathologic factors and disease free and overall survival were analyzed.

RESULTS

The 3- and 5-year disease free survival rates of the 104 study subjects were 62.2% and 57.7%, respectively, and overall survival rates were 69.4% and 60.1%, respectively. Multivariate analysis showed that an advanced T stage (P = 0.049), the presence of lymph node metastasis (P = 0.003), poor differentiation (P = 0.039), and the pancreatobiliary type (P = 0.022) significantly increased the risk of recurrence. Furthermore, the pancreatobiliary type was found to be more associated with an advanced T stage (P = 0.009), regional lymph node metastasis (P = 0.007), and perineural invasion (P = 0.026) than the intestinal type. In addition, pathologic subtype analysis showed that Carcinoembryonic antigen (CEA) level and lymph node metastasis were important predictors of recurrence in patients with the intestinal (P = 0.013) and pancreatobiliary types, respectively (P = 0.003).

CONCLUSIONS

An advanced T stage, nodal metastasis, poor differentiation, and the pancreaticobiliary type were found to be independent predictors of recurrence after curative resection of ampullary carcinoma by multivariate analysis. In addition, the pancreatobiliary type tended to present in a more advanced T stage and more frequently with regional lymph node involvement and perineural invasion than the intestinal type. Furthermore, CEA level and lymph node metastasis were found to be independent predictors of recurrence for the intestinal and pancreatobiliary types, respectively.

摘要

背景

相较于远端胆管癌和胰腺癌,壶腹癌的预后更好,近期出版物强调了肠型和胰胆型壶腹癌的组织学分化对预后的重要性。本研究旨在确定影响根治性切除术后复发的因素,并研究这两种病理亚型的临床病理特征差异。

方法

回顾性分析我院自 1995 年 2 月至 2009 年 3 月期间因壶腹癌行胰十二指肠切除术的患者的病历。本研究纳入了 104 例接受根治性切除的壶腹癌患者。由一位病理学家对所有病理报告和组织病理学发现进行了审核。分析了临床病理因素、无病生存期和总生存期的数据。

结果

104 例研究对象的 3 年和 5 年无病生存率分别为 62.2%和 57.7%,总生存率分别为 69.4%和 60.1%。多因素分析显示,T 期较晚(P=0.049)、存在淋巴结转移(P=0.003)、分化差(P=0.039)和胰胆型(P=0.022)显著增加了复发风险。此外,与肠型相比,胰胆型与 T 期较晚(P=0.009)、区域淋巴结转移(P=0.007)和神经周围侵犯(P=0.026)更为相关。此外,病理亚型分析显示,CEA 水平和淋巴结转移是肠型(P=0.013)和胰胆型(P=0.003)患者复发的重要预测因素。

结论

多因素分析显示,T 期较晚、淋巴结转移、分化差和胰胆型是根治性切除术后壶腹癌复发的独立预测因素。此外,与肠型相比,胰胆型更倾向于表现为更晚期的 T 期,并更常伴有区域淋巴结受累和神经周围侵犯。此外,CEA 水平和淋巴结转移分别是肠型和胰胆型复发的独立预测因素。

相似文献

1
Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.根治性切除治疗 Vater 壶腹癌的病理亚型的临床意义。
J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090. Epub 2011 Aug 31.
2
Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.壶腹癌根治性切除术后组织学类型和神经周围侵犯作为预后因素的意义分析
Hepatogastroenterology. 2010 May-Jun;57(99-100):646-52.
3
Tumors of the ampulla of vater: histopathologic classification and predictors of survival.Vater壶腹肿瘤:组织病理学分类及生存预测因素
J Am Coll Surg. 2008 Aug;207(2):210-8. doi: 10.1016/j.jamcollsurg.2008.01.028. Epub 2008 May 5.
4
Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.壶腹癌根治性切除术后的复发及预后因素:与肝外胆管远端癌的比较
Ann Surg Oncol. 2007 Nov;14(11):3195-201. doi: 10.1245/s10434-007-9537-y. Epub 2007 Aug 19.
5
Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.预测壶腹腺癌患者生存和病理亚型的因素。
J Surg Oncol. 2014 Aug;110(2):156-62. doi: 10.1002/jso.23600. Epub 2014 Mar 12.
6
Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?肠型和胰胆管型腺癌:壶腹癌与其他壶腹周围恶性肿瘤有何不同?
Ann Surg Oncol. 2013 Feb;20(2):430-9. doi: 10.1245/s10434-012-2603-0. Epub 2012 Sep 7.
7
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.壶腹癌根治性切除术后淋巴结比率及切除淋巴结数量的预后相关性
Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.
8
Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.壶腹癌胰十二指肠切除术后失败模式的预测因素。
Ann Surg Oncol. 2007 Jan;14(1):50-60. doi: 10.1245/s10434-006-9136-3. Epub 2006 Oct 20.
9
Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.影响壶腹癌根治性切除术后复发的因素。
J Surg Oncol. 2007 Mar 15;95(4):286-90. doi: 10.1002/jso.20665.
10
Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater.淋巴结受累作为 Vater 乳头癌术后肝转移的指标。
J Hepatobiliary Pancreat Surg. 2006;13(6):549-55. doi: 10.1007/s00534-006-1113-5. Epub 2006 Nov 30.

引用本文的文献

1
Adjuvant Chemotherapy Is Associated with Improved Survival in Advanced Ampullary Adenocarcinoma-A Population-Based Analysis by the German Cancer Registry Group.辅助化疗与晚期壶腹腺癌生存率提高相关——德国癌症登记组基于人群的分析
J Clin Med. 2025 May 30;14(11):3869. doi: 10.3390/jcm14113869.
2
Oncologic effect of preoperative endoscopic sphincterotomy in patients undergoing pancreaticoduodenectomy for ampulla of vater cancer.术前内镜下括约肌切开术对因 Vater 壶腹癌行胰十二指肠切除术患者的肿瘤学影响。
Langenbecks Arch Surg. 2025 May 16;410(1):161. doi: 10.1007/s00423-025-03730-8.
3
A Rare Case of Ampullary Carcinoma with Complete Duodenal Obstruction as the Initial Manifestation.
以完全性十二指肠梗阻为首发表现的壶腹癌罕见病例。
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0020. Epub 2025 Apr 16.
4
Prognostic significance of necrosis in ampullary carcinomas.壶腹癌中坏死的预后意义。
Ir J Med Sci. 2024 Oct;193(5):2179-2185. doi: 10.1007/s11845-024-03740-3. Epub 2024 Jun 26.
5
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.可切除壶腹癌患者的临床病理分析及生存预后因素:多机构回顾性经验。
Medicina (Kaunas). 2024 May 16;60(5):818. doi: 10.3390/medicina60050818.
6
Expression Profile of KRAS and p16 in Periampullary Cancer.壶腹周围癌中KRAS和p16的表达谱
Indian J Surg Oncol. 2024 Mar;15(1):25-34. doi: 10.1007/s13193-023-01819-4. Epub 2023 Sep 15.
7
Machine learning for differentiating between pancreatobiliary-type and intestinal-type periampullary carcinomas based on CT imaging and clinical findings.基于CT成像和临床发现的机器学习用于鉴别胰胆管型和肠型壶腹周围癌
Abdom Radiol (NY). 2024 Mar;49(3):748-761. doi: 10.1007/s00261-023-04151-1. Epub 2024 Jan 18.
8
Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.基于免疫组织化学染色的 Vater 壶腹癌亚型分类的临床影响。
World J Surg Oncol. 2024 Jan 3;22(1):5. doi: 10.1186/s12957-023-03289-y.
9
Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis.壶腹癌环周切缘对生存的影响:回顾性分析。
BJS Open. 2023 Nov 1;7(6). doi: 10.1093/bjsopen/zrad120.
10
Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study.壶腹腺癌姑息化疗的结果:一项多中心队列研究。
Gut Liver. 2024 Jul 15;18(4):729-736. doi: 10.5009/gnl230164. Epub 2023 Dec 22.